Search

everythinglearnresearchcommunity

for

Search:↓

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Computational methods can speed up and improve the development and safety of herbal drugs.

New patents include innovations in skin and hair care, disease treatment, plant stress tolerance, and protein purification.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Vaccination and timely treatment reduce the risk of long COVID.

People with blood group O may have a higher risk of developing post-COVID-19 syndrome.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

SIM01 significantly reduced post-COVID symptoms and is safe.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

During the COVID-19 pandemic, more people were diagnosed with stress-related skin conditions like acne and temporary hair loss.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Long COVID is a serious, long-lasting illness that needs more recognition and support.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

No significant link between male pattern baldness and COVID-19 severity was found.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

Polymeric nanoparticles could improve hair loss treatments by delivering drugs more effectively to hair follicles.

Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Protein analysis shows aging changes in scalp cell types from women.